 | Too Big to Succeed: Where are Large Pharmas Heading?
The biopharmaceutical industry's largest companies have grown too large to offer shareholders a compelling return. L.E.K.'s analysis shows how pharma companies can address their most pressing challenges, including key internal issues such as scale as a core foundation of their growth aspirations.
Download the free whitepaper. |
 | Health Care & Policy |  |  | | - Study quantifies the Human Genome Project's huge economic impact
The U.S.' $14.5 billion investment in the Human Genome Project has added $966 billion to the economy and $59 billion in federal tax revenue, a study by United for Medical Research and Battelle found. The project spawned dozens of companies as well as new drugs and diagnostics. "This report illustrates the vital role that key federal research funding plays in growing the U.S. economy, creating new industries and innovative technologies and producing the diagnostics and treatments that can save lives," said United for Medical Research President Carrie Wolinetz. Bloomberg (6/12)       - NICE endorses Jetrea as option for severe vitreomacular traction
The U.K. National Institute for Health and Care Excellence released draft guidance endorsing ThromboGenics and Novartis' eye treatment Jetrea as a surgical alternative for adults with severe vitreomacular traction. The drug is recommended for severe symptoms such as torn retinas, but not for patients with an epiretinal membrane. NICE said Jetrea is a cost-effective drug, each injection of which will cost about $3,900 in the U.S. Bloomberg Businessweek (6/11) | Company & Financial News | | | | - Va. firm obtains funds to advance bleeding disorder Dx
Charlottesville, Va.-based HemoSonics has secured almost $1.3 million, which it will use to further develop a device to diagnose clotting disorders that can lead to stroke, hemorrhage and other complications during surgery. The Point of Care Analyzer is targeted initially for use in open-heart surgery, with eventual applications in trauma care and for a variety of procedures. MedCityNews.com (6/11) | Industry Deals | | | | | Food & Agriculture | | | | - Flaws found in study linking biotech feed to poor pig health
A study in the Journal of Organic Systems connecting biotech foods to stomach inflammation in pigs had major flaws, according to several scientists who reviewed the paper. Critics questioned the statistical methods used to analyze the small study's data, saying that the results did not support the conclusions reached by the study's authors. Business Insider (6/12) | Industrial & Environmental | | | | - Farm-bill energy programs less secure in House bill
Whether funding for clean and renewable energy programs under the farm bill continues at lower levels or disappears depends on House lawmakers, Kathiann M. Kowalski writes. The farm bill passed by the Senate this week provides a mandatory $900 million for energy programs over five years, but the House version makes that funding discretionary. That could lead to "some very gutted programs," said Andy Olsen, a policy adviser at the Environmental Law and Policy Center. Midwest Energy News (6/12) | News from BIO | | | | - Secure document sharing services optimized for life science organizations
ShareVault, a leading provider of highly secure and controlled document sharing solutions and virtual data rooms (VDR), has aligned with BIO to provide companies with significant discounted pricing and complimentary extra features. ShareVault's VDR platform is optimized for life science companies of all sizes and flexibly priced so that even small biotech companies can afford and benefit from its technology. The ShareVault solution is intended for due diligence required during bio-pharma partnering, licensing, fundraising, M&A, clinical study management or other applications that require secure sharing of documents with third parties. Learn more and sign up for a free trial.
| SmartQuote | | | |  | I want to live my life so that my nights are not full of regrets."
--D.H. Lawrence,
British novelist  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Wednesday, June 12, 2013
- Tuesday, June 11, 2013
- Monday, June 10, 2013
- Friday, June 07, 2013
- Thursday, June 06, 2013
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2013 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment